The PE Ratio as of September 2024 (TTM) for Pharvaris N.V. (PHVS) is -5.99

According to Pharvaris N.V.’s latest financial reports and current stock price. The company's current PE Ratio is -5.99. This represents a change of -34.32% compared to the average of -9.12 of the last 4 quarters.

Pharvaris N.V. (PHVS) Historical PE Ratio (quarterly & annually)

How has PHVS PE Ratio performed in the past?

The mean historical PE Ratio of Pharvaris N.V. over the last ten years is -36.23. The current -5.99 PE Ratio has changed 1.55% with respect to the historical average. Over the past ten years (40 quarters), PHVS's PE Ratio was at its highest in in the June 2023 quarter at 163.52. The PE Ratio was at its lowest in in the December 2018 quarter at -186.63.

Pharvaris N.V. (PHVS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Pharvaris N.V. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Pharvaris N.V. (PHVS) Average PE Ratio

How has PHVS PE Ratio performed in the past?

The current PE Ratio of Pharvaris N.V. (PHVS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Pharvaris N.V. (PHVS) PE Ratio vs. Peers

How is PHVS’s PE Ratio compared to its peers?

Pharvaris N.V.’s PE Ratio is less than PMV Pharmaceuticals, Inc. (-1.58), less than Eliem Therapeutics, Inc. (-3.49), greater than MediciNova, Inc. (-12.61), less than PepGen Inc. (-3.22), less than Molecular Partners AG (-2.67), less than Mineralys Therapeutics, Inc. (-4.63), less than AN2 Therapeutics, Inc. (-0.47), less than Monte Rosa Therapeutics, Inc. (-3.11), less than Design Therapeutics, Inc. (-5.23), less than Werewolf Therapeutics, Inc. (-1.64), less than Ikena Oncology, Inc. (-1.22), greater than Stoke Therapeutics, Inc. (-7.92), greater than Tyra Biosciences, Inc. (-14.94), less than Anebulo Pharmaceuticals, Inc. (-4.99), greater than Janux Therapeutics, Inc. (-51.01), less than Rezolute, Inc. (-3.80),

Build a custom stock screener for Pharvaris N.V. (PHVS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pharvaris N.V. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Pharvaris N.V. (PHVS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Pharvaris N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.